| Name | Title | Contact Details |
|---|
Point Pickup Technologies (PPUP) is a technology enabled platform (services) company disrupting legacy transportation models to solve middle and last mile delivery.
Boundless is a new technology company providing immigrants with the tools, information, and personalized support to navigate their immigration journey with confidence.
Nudge is a developer of proprietary coffee technologies.
Eaze (eaze.com), the leading cannabis technology company, is on a mission to help people enjoy the moment through convenient access to high quality marijuana products. Founded in 2014, the company`s technology enables superior customer choice and convenience by connecting product brands, dispensaries and doctors to customers on demand. With over 300,000 users in California, Eaze has unprecedented access to big data regarding cannabis market trends and consumer preferences which it shares with industry and media partners through its Eaze Insights Program. Eaze has raised over $52m from investors such as DCM Ventures, Bailey Capital, and 500 Startups, and is one of the first tech companies to receive large scale institutional investment in the cannabis industry. eaze currently works with legal dispensaries that serve California cities across the Bay Area, parts of Los Angeles County, Orange County and San Diego County.
ChroMedX Corp. is a medical technology company focused on the development of novel, handheld medical devices for diagnostic testing at the patient`s bedside. HemoPalm, the Company`s lead product is the only handheld blood analysis system which combines Blood Gases & Electrolytes with full CO-oximetry. It has a single-use cartridge/handheld reader format, providing the simplest, most rapid and accurate testing process for use in management of critical care patients. Current blood gas systems require purchase of a second device to carry out CO-oximetry measurements. In addition, HemoPalm has the ability to draw capillary blood directly from pin-prick sites into the cartridge, as an alternative to the commonly required, risk-associated arterial blood draws. ChroMedX Corp. technologies are protected by the Company`s issued and pending patents, covering blood/plasma/serum collection, and processing and analysis.